Research / DHR / Fundamental state Inspectable configuration
State dimensions Filing 0000313616-21-000098 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
282.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.23% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
29.37% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
36.26% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
60.92% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
27.78% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.90% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.73% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 26 states Self-history eligible
Oct 1, 2021 0/8 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Apr 1, 2022 7/9 normalized Level 3 Jul 1, 2022 7/9 normalized Level 3 Sep 30, 2022 7/9 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 8/9 normalized Level 3 Sep 29, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 29, 2024 9/9 normalized Level 3 Jun 28, 2024 9/9 normalized Level 3 Sep 27, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 28, 2025 9/9 normalized Level 3 Jun 27, 2025 9/9 normalized Level 3 Sep 26, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 27, 2026 9/9 normalized Level 3 Jun 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 295.67%
Current 282.95%
Delta -12.72% Capex Intensity Increased
Previous 3.66%
Current 4.23%
Delta 0.57% Cash Generation Increased
Previous 27.28%
Current 29.37%
Delta 2.09% Growth Decreased
Previous 57.91%
Current 36.26%
Delta -21.65% Margin Decreased
Previous 62.02%
Current 60.92%
Delta -1.10% Profitability Decreased
Previous 29.12%
Current 27.78%
Delta -1.34% R And D Intensity Increased
Previous 5.54%
Current 5.90%
Delta 0.36% Sbc Intensity Decreased
Previous 0.79%
Current 0.73%
Delta -0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.